MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Neogen Corporation EBITDA per Share 2011-2026 | NEOG
Annual EBITDA per Share Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.34 | 0.81 | 0.67 | 0.76 | 0.89 | 0.82 | 0.821 | 0.843 | 0.782 | 0.688 | 0.644 | 0.537 | 0.5 | 0.422 | 0.447 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.89 | -4.34 | 0.353 |
Quarterly EBITDA per Share Neogen Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.06 | - | - | - | 0.15 | - | 0.16 | 0.18 | 0.22 | - | 0.18 | 0.07 | 0.11 | 0.29 | 0.08 | 0.14 | 0.26 | 0.43 | 0.15 | 0.18 | 0.22 | 0.54 | 0.25 | 0.35 | 0.4 | 0.52 | 0.4 | 0.35 | 0.4 | 0.52 | 0.4 | 0.35 | 0.4 | 0.51 | 0.53 | 0.33 | 0.48 | 0.63 | 0.48 | 0.39 | 0.47 | 0.54 | 0.33 | 0.35 | 0.43 | 0.49 | 0.43 | 0.27 | 0.4 | 0.38 | 0.6 | 0.29 | 0.5 | 0.58 | 0.5 | 0.35 | 0.46 | 0.47 | 0.46 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.63 | 0.06 | 0.359 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.49 | $ 114.25 | -1.07 % | $ 34.7 B |  USA |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.64 | 3.53 % | $ 85.7 K | USA |
|
Biodesix
BDSX
|
-0.22 | $ 15.55 | 3.19 % | $ 2.02 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
-4.37 | $ 1.2 | -0.03 % | $ 6.53 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 16.5 | 1.85 % | $ 178 M |  China |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 18.32 | 0.05 % | $ 976 M | USA |
 |
Celcuity
CELC
|
-3.68 | $ 113.8 | 1.04 % | $ 5.32 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 168.44 | -3.13 % | $ 8.35 B | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 24.85 | 0.04 % | $ 690 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 197.89 | 0.37 % | $ 22 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 190.62 | -0.26 % | $ 136 B | USA |
 |
DexCom
DXCM
|
2.98 | $ 62.7 | 0.76 % | $ 24.5 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 16.8 | -0.15 % | $ 508 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 92.35 | -1.58 % | $ 11.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 110.38 | -3.34 % | $ 9.1 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 127.63 | 0.2 % | $ 20.3 B | USA |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
IQVIA Holdings
IQV
|
19.4 | $ 168.24 | -2.9 % | $ 28.9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 274.94 | 0.41 % | $ 22.9 B | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 76.0 | -0.14 % | $ 5.13 B | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 485.89 | -2.5 % | $ 14 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 258.2 | -0.3 % | $ 25.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.84 | 1.79 % | $ 448 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.27 | $ 4.69 | - | $ 3.69 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 8.06 | 0.75 % | $ 1.03 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 17.35 | 1.11 % | $ 388 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 207.01 | -0.46 % | $ 20.4 B | USA |
 |
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.36 | 1.49 % | $ 408 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 27.09 | -0.07 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
0.03 | $ 25.23 | -1.29 % | $ 40.5 M | USA |
 |
Personalis
PSNL
|
-0.97 | $ 6.63 | 0.76 % | $ 393 M | USA |
 |
RadNet
RDNT
|
2.85 | $ 55.12 | 0.6 % | $ 4.14 B | USA |